gefarnate Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
1281 51-77-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • gefarnate
  • dixnalate
  • gefarnyl
  • geranyl farnesylacetate
A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.
  • Molecular weight: 400.65
  • Formula: C27H44O2
  • CLOGP: 10.01
  • LIPINSKI: 1
  • HAC: 2
  • HDO: 0
  • TPSA: 26.30
  • ALOGS: -5.59
  • ROTB: 15

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC A02BX07 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
ATC A02BX77 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
MeSH PA D000897 Anti-Ulcer Agents
MeSH PA D005765 Gastrointestinal Agents

Drug Use (View source of the data)

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01529 KEGG_DRUG
C0017226 UMLSCUI
CHEBI:31646 CHEBI
CHEMBL2105085 ChEMBL_ID
D005778 MESH_DESCRIPTOR_UI
DB12079 DRUGBANK_ID
5282182 PUBCHEM_CID
1546 INN_ID
1ISE2Y6ULA UNII

Pharmaceutical products:

None